Accreditation for cell-mediated immune response assay services

This accreditation will enable companies worldwide to incorporate ProImmune’s GLP- and Good Clinical Practice (GCP)-compliant services, such as cell-mediated immunity assays, into their preclinical and clinical development programmes with the confidence that the data will meet the different international regulatory submission requirements. Cell-mediated immune response assays are notoriously difficult, time-consuming and costly to implement in-house. Therefore, access to ProImmune’s GLP- and GCP-compliant assays provides an outsourcing solution for developers of new therapies.
www.proimmune.com